Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Epilepsy (Tiagabine - Epilepsy)

Records returned : 39 (on 29 May 2025 at 12:57:21). Return to search results for ' Epilepsy '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Tiagabine

Drug:

Tiagabine

Indication :

Epilepsy

Status :

Non Formulary

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

2. Brivaracetam

Drug:

Brivaracetam

Indication :

Epilepsy

Status :

Blue

Formulations :

Oral solution
Tablets

Restrictions / Comments:

Important

Reserved for patients who remain uncontrolled or intolerant to all other adjuntive anti-epileptics. Only for use when levetiracetam has not been effective or tolerated.

To be initiated by a specialist.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

30. Brivaracetam

Drug:

Brivaracetam

Indication :

Epilepsy

Status :

Red

Formulations :

Injection

Restrictions / Comments:

Important

Reserved for patients who remain uncontrolled or intolerant to all other adjuntive anti-epileptics. Only for use when levetiracetam has not been effective or tolerated.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

3. Carbamazepine

Drug:

Carbamazepine

Indication :

Epilepsy

Status :

Blue

Formulations :

Modified release tablets
Oral suspension
Suppositories
Tablets

Restrictions / Comments:

Important

Ensure that the patient is maintained on a specific manufacturer’s product

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

4. Clobazam

Drug:

Clobazam

Indication :

Epilepsy

Status :

Blue

Formulations :

Oral suspension
Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

5. Clonazepam

Drug:

Clonazepam

Indication :

Epilepsy

Status :

Blue

Formulations :

Oral solution
Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

6. Ethosuximide

Drug:

Ethosuximide

Indication :

Epilepsy

Status :

Blue

Formulations :

Capsules
Oral solution

Restrictions / Comments:

Important

For absence, atypical and myoclonic seizures

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

7. Gabapentin

Drug:

Gabapentin

Indication :

Epilepsy

Status :

Blue

Formulations :

Capsules
Oral solution
Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

8. Lacosamide

Drug:

Lacosamide

Indication :

Epilepsy

Status :

Blue

Formulations :

Oral solution
Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

33. Lacosamide

Drug:

Lacosamide

Indication :

Epilepsy

Status :

Red

Formulations :

Infusion

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

9. Lamotrigine

Drug:

Lamotrigine

Indication :

Epilepsy

Status :

Blue

Formulations :

Dispersible tablets
Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

10. Levetiracetam

Drug:

Levetiracetam

Indication :

Epilepsy

Status :

Blue

Formulations :

Oral solution
Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

11. Levetiracetam

Drug:

Levetiracetam

Indication :

Epilepsy

Status :

Blue

Formulations :

Granules

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

34. Levetiracetam

Drug:

Levetiracetam

Indication :

Epilepsy

Status :

Red

Formulations :

Infusion

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

12. Oxcarbazepine

Drug:

Oxcarbazepine

Indication :

Epilepsy

Status :

Blue

Formulations :

Oral suspension
Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

13. Perampanel

Drug:

Perampanel

Indication :

Epilepsy

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Important

Requires specialist initiation and supply for at least 12 weeks prior to a transfer of care to primary care prescribers

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

14. Phenobarbital

Drug:

Phenobarbital

Indication :

Epilepsy

Status :

Blue

Formulations :

Elixir
Tablets

Restrictions / Comments:

Important

Ensure that the patient is maintained on a specific manufacturer’s product

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

15. Phenobarbital

Drug:

Phenobarbital

Indication :

Epilepsy

Status :

Blue

Formulations :

Liquid

Restrictions / Comments:

Important

Ensure that the patient is maintained on a specific manufacturer’s product

Unlicensed phenobarbital liquid 50mg/5ml (sugar and alcohol free) for paediatric use (as recommended by the RCPCH and NPPG).

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

16. Phenytoin

Drug:

Phenytoin

Indication :

Epilepsy

Status :

Blue

Formulations :

Capsules
Oral suspension
Tablets

Restrictions / Comments:

Important

Ensure that the patient is maintained on a specific manufacturer’s product. Phenytoin sodium is NOT EQUIVALENT to Phenytoin base (suspension). When switching between products, 100mg of phenytoin sodium is approximately equivalent to 92mg of phenytoin base.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

17. Pregabalin

Drug:

Pregabalin

Indication :

Epilepsy

Status :

Blue

Formulations :

Capsules
Oral solution

Restrictions / Comments:

Important

Capsules are more cost effective than tablets

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

18. Primidone

Drug:

Primidone

Indication :

Epilepsy

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Important

Prescribe by brand - ensure patient is maintained on a specific product.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

19. Sodium valproate (NON childbearing potential)

Drug:

Sodium valproate (NON childbearing potential)

Indication :

Epilepsy

Status :

Blue

Formulations :

Crushable tablets
Gastro-resistant tablets
Modified release tablets
Oral solution
Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

20. Sodium valproate (NON childbearing potential)

Drug:

Sodium valproate (NON childbearing potential)

Indication :

Epilepsy

Status :

Blue

Formulations :

Capsules (slow release)
Granules (slow release)

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

35. Sodium valproate (NON childbearing potential)

Drug:

Sodium valproate (NON childbearing potential)

Indication :

Epilepsy

Status :

Red

Formulations :

Injection

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

21. Topiramate

Drug:

Topiramate

Indication :

Epilepsy

Status :

Blue

Formulations :

Capsules
Oral suspension
Tablets

Restrictions / Comments:

Important

Pregnancy Prevention Plan required for females of childbearing potential.

Capsules (Sprinkle) reserved for use in patients who cannot swallow tablets. Liquid reserved for patients who cannot swallow tablets or capsules

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

22. Vigabatrin

Drug:

Vigabatrin

Indication :

Epilepsy

Status :

Blue

Formulations :

Sachets (powder)
Tablets

Restrictions / Comments:

Important

Specialist initiation before transfer of prescribing to primary care

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

39. Vigabatrin

Drug:

Vigabatrin

Indication :

Epilepsy

Status :

Non Formulary

Formulations :

Soluble tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

23. Zonisamide

Drug:

Zonisamide

Indication :

Epilepsy

Status :

Blue

Formulations :

Capsules

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

24. Zonisamide

Drug:

Zonisamide

Indication :

Epilepsy

Status :

Blue

Formulations :

Oral suspension

Restrictions / Comments:

Important

Zonisamide 20mg/ml is the only licensed oral suspension available.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

25. Eslicarbazepine acetate

Drug:

Eslicarbazepine acetate

Indication :

Epilepsy

Status :

Amber

Formulations :

Tablets

Restrictions / Comments:

Important

Only when 1st-line and 1st-line adjunctive agents have been unsuccessful

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

26. Rufinamide

Drug:

Rufinamide

Indication :

Epilepsy

Status :

Amber

Formulations :

Tablets

Restrictions / Comments:

Important

SASH - restricted to paediatrics only. RSCH - only initiate on recommendation from a tertiary referral centre.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

27. Rufinamide

Drug:

Rufinamide

Indication :

Epilepsy

Status :

Amber

Formulations :

Oral suspension

Restrictions / Comments:

Important

RSCH - only initiate on recommendation from a tertiary referral centre.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

28. Sodium valproate (with childbearing potential)

Drug:

Sodium valproate (with childbearing potential)

Indication :

Epilepsy

Status :

Amber

Formulations :

Capsules (slow release)
Granules (slow release)

Restrictions / Comments:

Important

Pregnancy Prevention Programme required. See MHRA advice

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

29. Sodium valproate (with childbearing potential)

Drug:

Sodium valproate (with childbearing potential)

Indication :

Epilepsy

Status :

Amber

Formulations :

Crushable tablets
Gastro-resistant tablets
Modified release tablets
Oral solution
Tablets

Restrictions / Comments:

Important

Pregnancy Prevention Programme required. See MHRA advice

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

36. Sodium valproate (with childbearing potential)

Drug:

Sodium valproate (with childbearing potential)

Indication :

Epilepsy

Status :

Red

Formulations :

Injection

Restrictions / Comments:

Important

Pregnancy Prevention Programme required. See MHRA advice

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

31. Cannabis (medicinal)

Drug:

Cannabis (medicinal)

Indication :

Epilepsy

Status :

Red

Formulations :

Oral solution

Restrictions / Comments:

Important

Specialist centres only (including ongoing supply)

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

32. Cenobamate

Drug:

Cenobamate

Indication :

Epilepsy

Status :

Red

Formulations :

Tablets

Restrictions / Comments:

Important

For initiation by tertiary centres only

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

37. Stiripentol

Drug:

Stiripentol

Indication :

Epilepsy

Status :

Red

Formulations :

Capsules

Restrictions / Comments:

Important

Initiation and adjustment by consultant paediatricians only.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

38. Sulthiame

Drug:

Sulthiame

Indication :

Epilepsy

Status :

Non Formulary

Formulations :

Oral suspension

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD2